Skip to main content

Advertisement

SpringerLink
Log in

Caveats in the use of potassium iodide for thyroid blocking

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Sase E, Eddy C, Polivka BJ. Lessons from Fukushima: potassium iodide after a nuclear disaster. Am J Nurs. 2021;121:63–7. https://doi.org/10.1097/01.NAJ.0000734144.20889.b0.

    Article  PubMed  Google Scholar 

  2. Burchert W, Fehringer F, Kirchinger W, Kopp J, Port M, Reiners C, et al. Use of iodine tablets for thyroid blocking in the event of a nuclear emergency with release of radioactive iodine. Bonn: German Commission on Radiological Protection - Strahlenschutzkommission; 2019.

    Google Scholar 

  3. Iodine thyroid blocking - guidelines for use in planning for and responding to radiological and nuclear emergencies. Geneva: World Health Organization; 2017.

  4. Reiners C, Schneider R. Potassium iodide (KI) to block the thyroid from exposure to I-131: current questions and answers to be discussed. Radiat Environ Biophys. 2013;52:189–93. https://doi.org/10.1007/s00411-013-0462-0.

    Article  CAS  PubMed  Google Scholar 

  5. Agopiantz M, Elhanbali O, Demore B, Cuny T, Demarquet L, Ndiaye C, et al. Thyroid side effects prophylaxis in front of nuclear power plant accidents. Ann Endocrinol (Paris). 2016;77:1–6. https://doi.org/10.1016/j.ando.2015.12.003.

    Article  Google Scholar 

  6. Zanzonico PB, Becker DV. Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout. Health Phys. 2000;78:660–7. https://doi.org/10.1097/00004032-200006000-00008.

    Article  CAS  PubMed  Google Scholar 

  7. Adalja AA. Use of potassium iodide (KI) in a nuclear emergency. Biosecur Bioterror. 2011;9:405–7. https://doi.org/10.1089/bsp.2011.1026.

    Article  PubMed  Google Scholar 

  8. Chiovato L, Magri F, Carlé A. Hypothyroidism in context: where we’ve been and where we’re going. Adv Ther. 2019;36:47–58. https://doi.org/10.1007/s12325-019-01080-8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Zimmermann MB, Andersson M. Global endocrinology: global perspectives in endocrinology: coverage of iodized salt programs and iodine status in 2020. Eur J Endocrinol. 2021;185:R13–21. https://doi.org/10.1530/eje-21-0171.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bähre M, Hilgers R, Lindemann C, Emrich D. Physiological aspects of the thyroid trapping function and its suppression in iodine deficiency using 99mTc pertechnetate. Acta Endocrinol (Copenh). 1987;115:175–82. https://doi.org/10.1530/acta.0.1150175.

    Article  Google Scholar 

  11. Ramos CD, Zantut-Wittmann DE, Tambascia MA, Assumpção L, Etchebehere EC, Camargo EE. Thyroid suppression test with L-thyroxine and [99mTc] pertechnetate. Clin Endocrinol (Oxf). 2000;52:471–7. https://doi.org/10.1046/j.1365-2265.2000.00898.x.

    Article  CAS  Google Scholar 

  12. Reinhardt MJ, Högerle S, Trupkovic T, Krause TM, Moser E. Influence of urinary iodine excretion on thyroid technetium-99m pertechnetate uptake with and without TSH suppression: what happens when iodine supply increases? Eur J Nucl Med. 1998;25:1475–81. https://doi.org/10.1007/s002590050324.

    Article  CAS  PubMed  Google Scholar 

  13. Philippou G, Koutras DA, Piperingos G, Souvatzoglou A, Moulopoulos SD. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement. Clin Endocrinol (Oxf). 1992;36:573–8. https://doi.org/10.1111/j.1365-2265.1992.tb02267.x.

    Article  CAS  Google Scholar 

  14. Giovanella L, Avram AM, Iakovou I, Kwak J, Lawson SA, Lulaj E, et al. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur J Nucl Med Mol Imaging. 2019;46:2514–25. https://doi.org/10.1007/s00259-019-04472-8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Ippokration Hospital, 54642, Thessaloniki, Greece

    Georgios Meristoudis

  2. Department of Endocrinology, Elena Venizelou General and Maternity Hospital, 11521, Athens, Greece

    Ioannis Ilias

Authors
  1. Georgios Meristoudis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ioannis Ilias
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation and writing were performed by Georgios Meristoudis and Ioannis Ilias. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Ioannis Ilias.

Ethics declarations

There are no ethics, consent, or data issues.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Letter to the Editor

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meristoudis, G., Ilias, I. Caveats in the use of potassium iodide for thyroid blocking. Eur J Nucl Med Mol Imaging 49, 2120–2121 (2022). https://doi.org/10.1007/s00259-022-05797-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-022-05797-7

Search

Navigation